Inventor · disambiguated record
Steven Burke
Also filed as: BURKE STEVEN · BURKE STEVEN K · BURKE STEVEN KEITH
6 granted patents·18 pending applications·133 citations·filing 1997–2024
85Inventor score
Files withGENZYME CORP6AKEBIA THERAPEUTICS INC5BURKE STEVEN K3GELTEX PHARMA INC3GELTEX PHARMACEUTICAL INC2
Top patents by PatentIndex Score
24 records- 0190US6423754B1Method for treating hypercholesterolemia with polyallylamine polymersGELTEX PHARMA INC·Filed 1997·Granted Jul 23, 2002·75 cites·3 claims
- 0287US7220406B2Method for promoting bone formationGENZYME CORP·Filed 2003·Granted May 22, 2007·26 cites·30 claims
- 0382US8377428B2Low salt forms of polyallylamineGENZYME CORP·Filed 2009·Granted Feb 19, 2013·4 cites·10 claims
- 0481US7229613B2Method for lowering serum glucoseGENZYME CORP·Filed 2002·Granted Jun 12, 2007·19 cites·4 claims
- 0574US2025352527A1Methods for treating viral infections, organ injury, and related conditionsAKEBIA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0671US7541024B2Low salt forms of polyallylamineGENZYME CORP·Filed 2002·Granted Jun 2, 2009·4 cites·7 claims
- 0770US2023144457A1Methods for treating viral infections, organ injury, and related conditionsAKEBIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0867US7261880B2Methods of treating Syndrome X with aliphatic polyaminesGENZYME CORP·Filed 2002·Granted Aug 28, 2007·5 cites·2 claims
- 0961US2021322301A1Dosing regimens for treating metal-mediated conditionsABFERO PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1059US2024325360A1Therapeutic methods using vadadustatAKEBIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1159US2024148707A1Modulation of drug-drug interactions of vadadustatAKEBIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1258US2009304623A1Once A Day Formulation for Phosphate BindersGENZYME CORP·Filed 2009·Application pending·0 cites
- 1355US2023218592A1Treatment of viral infections, of organ injury, and of related conditions using a hif prolyl hydroxylase inhibitor or a hif-alpha stabilizerAKEBIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1455US2006239959A1Method for treating hypercholesterolemia with polyallylamine polymersHOLMES-FARLEY STEPHEN R·Filed 2006·Application pending·0 cites
- 1554US2008112918A1Method for treating gout and binding uric acidHOLMES-FARLEY STEPHEN RANDALL·Filed 2007·Application pending·0 cites
- 1651US2008057025A1Method for promoting bone formationBURKE STEVEN K·Filed 2007·Application pending·0 cites
- 1751US2003086898A1Method for treating hypercholesterolemia with polyallylamine polymersGELTEX PHARMA INC·Filed 2002·Application pending·0 cites
- 1848US2007286841A1Method for lowering serum glucoseBURKE & DONOVAN·Filed 2007·Application pending·0 cites
- 1948US2006177415A1Once a day formulation for phosphate bindersBURKE STEVEN K·Filed 2005·Application pending·0 cites
- 2048US2008085872A1Methods of treating Syndrome X with aliphatic polyaminesBURKE STEVEN K·Filed 2007·Application pending·0 cites
- 2147US2018036228A1Dosing regimens for treating metal-mediated conditionsBURKE STEVEN KEITH·Filed 2017·Application pending·0 cites
- 2246US2002187120A1Method for treating gout and reducing serum uric acidGELTEX PHARMACEUTICAL INC·Filed 2002·Application pending·0 cites
- 2344US2003039627A1Method for treating gout and binding uric acidGELTEX PHARMACEUTICAL INC·Filed 2002·Application pending·0 cites
- 2436US2002168333A1Method for improving vascular access in patients with vascular shuntsGELTEX PHARMA INC·Filed 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →